Streetbeat News

Analyst Ratings

AURA

JMP Securities has maintained a Market Outperform rating on Aura Biosciences and raised its price target from $19 to $23, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:18 am

ORCL

Guggenheim analyst John Difucci has maintained a Buy rating on Oracle and raised the price target from $185 to $200, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:15 am

AMT

BMO Capital analyst Ari Klein maintains an Outperform rating on American Tower (NYSE:AMT) and raises the price target from $246 to $260.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:08 am

ADBE

Bernstein analyst Mark Moerdler maintains an Outperform rating on Adobe but lowers the price target from $660 to $644.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:06 am

GMAB

HC Wainwright & Co. has reiterated its Buy rating on Genmab (NASDAQ:GMAB) and maintained a $50 price target, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:00 am

MRNA

Piper Sandler analyst Edward Tenthoff maintains an Overweight rating on Moderna but lowers the price target from $157 to $115.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:59 am

PLRX

HC Wainwright & Co. has reiterated its Buy rating for Pliant Therapeutics, maintaining a price target of $38.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:58 am

GIS

General Mills (NYSE:GIS) is set to release its Q1 earnings on Sept. 18, with expectations of $1.06 EPS and $4.79 billion in revenue. Analysts have revised price targets downward, reflecting cautious sentiment. The company recently sold its North American Yogurt business.

Portfolio Pulse from Avi Kapoor

September 13, 2024 | 10:54 am

ARM

Raymond James has initiated coverage on ARM Holdings with an Outperform rating and set a price target of $160.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:50 am

ROKU

Needham analyst Laura Martin has reiterated a Buy rating on Roku and maintained a $100 price target.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:48 am